when he does drink, he consumes 1-2 alcoholic beverages In terms of lifestyle, JM reports that he could eat better and that he engages in limited physical activity (estimated at 30 minutes per week of light walking) Laboratory and vital findings : Weight : 232 pounds (body mass index [BMI] = 34 kg/m 2 ) Blood pressure : 128/84 mmHg (average of 3 seated blood pressure readings) Blood glucose : 116 mg/dL (fasting) Point-of-care A1C : 7.1% Serum creatinine : 1.5 mg/dL eGFR : 50 mL/min/1.73 m 2 Sodium : 139 mEq/L Potassium : 4.9 mEq/L UACR : 60 mg/g (microalbuminuria) Low-density lipoprotein cholesterol (LDL-C): 88 mg/dL High-density lipoprotein cholesterol (HDL-C): 40 mg/dL Triglycerides: 148 mg/dL Case discussion JM provided some important information that will be helpful when determining a treatment plan to minimize his cardiovascular risk
These patches rely on herbal blends or vitamins, and theres no clinical evidence showing they work
GLP-1s, first approved for type 2 diabetes in 2005, lower blood glucose, help avoid fatty liver disease, and help with obesity-related problems such as knee pain, sleep apnea, and gastroesophageal reflux
Meanwhile, Pfizer is developing an oral GIP analogue, currently known as PF-07976016, which is to be administered daily